CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 41 filers reported holding CTI BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $584,000 | +889.8% | 97,805 | +432.0% | 0.05% | +733.3% |
| Q4 2020 | $59,000 | +353.8% | 18,385 | +16.9% | 0.01% | +500.0% |
| Q3 2019 | $13,000 | +44.4% | 15,723 | +49.3% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | -52.6% | 10,533 | -58.3% | 0.00% | 0.0% |
| Q4 2018 | $19,000 | -44.1% | 25,232 | +59.6% | 0.00% | -50.0% |
| Q3 2018 | $34,000 | -79.3% | 15,813 | -52.1% | 0.00% | -71.4% |
| Q2 2018 | $164,000 | -3.5% | 32,979 | -24.2% | 0.01% | -22.2% |
| Q1 2018 | $170,000 | +214.8% | 43,523 | +158.5% | 0.01% | +200.0% |
| Q3 2017 | $54,000 | – | 16,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,000,000 | $3,881,000 | 2.23% |
| BVF INC/IL | 6,929,690 | $6,723,000 | 0.75% |
| CAXTON CORP | 323,026 | $313,000 | 0.29% |
| NEA Management Company, LLC | 3,750,000 | $3,638,000 | 0.19% |
| Orbimed Advisors | 5,000,000 | $4,851,000 | 0.08% |
| Fosun International Ltd | 300,428 | $288,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 105,385 | $102,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,055 | $29,000 | 0.00% |
| Renaissance Technologies | 1,282,352 | $1,244,000 | 0.00% |
| WASHINGTON TRUST Co | 16,000 | $15,000 | 0.00% |